AU2001280705A1 - Human tumor necrosis factor receptors tr21 and tr22 - Google Patents

Human tumor necrosis factor receptors tr21 and tr22

Info

Publication number
AU2001280705A1
AU2001280705A1 AU2001280705A AU8070501A AU2001280705A1 AU 2001280705 A1 AU2001280705 A1 AU 2001280705A1 AU 2001280705 A AU2001280705 A AU 2001280705A AU 8070501 A AU8070501 A AU 8070501A AU 2001280705 A1 AU2001280705 A1 AU 2001280705A1
Authority
AU
Australia
Prior art keywords
necrosis factor
tumor necrosis
human tumor
factor receptors
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280705A
Other languages
English (en)
Inventor
Craig A Rosen
Steven M Ruben
Zhi-Zhen Zeng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2001280705A1 publication Critical patent/AU2001280705A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70578NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30 CD40 or CD95

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
AU2001280705A 2000-07-24 2001-07-23 Human tumor necrosis factor receptors tr21 and tr22 Abandoned AU2001280705A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22011600P 2000-07-24 2000-07-24
US60220116 2000-07-24
US22114300P 2000-07-27 2000-07-27
US60221143 2000-07-27
PCT/US2001/023124 WO2002007762A1 (fr) 2000-07-24 2001-07-23 Recepteurs de facteur de necrose tumorale humains tr21 et tr22

Publications (1)

Publication Number Publication Date
AU2001280705A1 true AU2001280705A1 (en) 2002-02-05

Family

ID=26914583

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280705A Abandoned AU2001280705A1 (en) 2000-07-24 2001-07-23 Human tumor necrosis factor receptors tr21 and tr22

Country Status (5)

Country Link
US (2) US20020098163A1 (fr)
EP (1) EP1313503A4 (fr)
AU (1) AU2001280705A1 (fr)
CA (1) CA2412408A1 (fr)
WO (1) WO2002007762A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148454A1 (en) * 2001-11-02 2003-08-07 Trustees Of Boston University Virus-free vesicles for delivery of functional membrane bound proteins
JP5268255B2 (ja) * 2003-11-21 2013-08-21 エイエヌピー テクノロジーズ, インコーポレイテッド 非対称分岐ポリマー抱合体およびマイクロアレイアッセイ
WO2021043290A1 (fr) * 2019-09-06 2021-03-11 Biocytogen Pharmaceuticals (Beijing) Co., Ltd Animal non humain génétiquement modifié avec un tnfr2 humaine ou chimérique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
WO1998054963A2 (fr) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 proteines secretees humaines
US6525174B1 (en) * 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
EP1080194A2 (fr) * 1998-05-29 2001-03-07 Incyte Pharmaceuticals, Inc. Proteines transmembranaires humaines
US6287808B1 (en) * 1998-09-03 2001-09-11 Millennium Pharmaceuticals, Inc. Molecules of the herpesvirus-entry-mediator-related protein family and uses thereof
EP1514933A1 (fr) * 1999-07-08 2005-03-16 Research Association for Biotechnology Protéine sécrétoire ou protéine de membrane

Also Published As

Publication number Publication date
WO2002007762A1 (fr) 2002-01-31
EP1313503A1 (fr) 2003-05-28
CA2412408A1 (fr) 2002-01-31
US20020098163A1 (en) 2002-07-25
US20050090436A1 (en) 2005-04-28
EP1313503A4 (fr) 2005-05-04

Similar Documents

Publication Publication Date Title
AU2001252504A1 (en) Combined impedance imaging and mammography
AU2003288086A1 (en) Covered conductor and heater formed therewith
AU2002252460A1 (en) Human cytokine receptor
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2001272974A1 (en) Human receptors
AU2001277959A1 (en) Human kinases
AU2001238488A1 (en) Human kinases
AU2001288612A1 (en) Human kinases
AU2003215257A1 (en) Modified defensins and their use
AU2001282856A1 (en) Human tumor necrosis factor delta and epsilon
AU2002232596A1 (en) Secreted human proteins
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2002227925A1 (en) Human beta-defensin-3
AU2003223878A1 (en) Heating conductor and use thereof
AU2001280705A1 (en) Human tumor necrosis factor receptors tr21 and tr22
AU2001277980A1 (en) Human cytokine receptor
AU4445701A (en) Multiple human and mouse otoferlin isoforms
AU2001276837A1 (en) Human and mouse g-protein couipled receptors
AU2002217984A1 (en) Erythropoietin and erythropoietin receptor expression in human cancer
AU2001294719A1 (en) Secreted human proteins
AU2002227352A1 (en) Human kinases
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses
AU2003296871A1 (en) Point feeder and use of point feeder
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use
AU2003240446A1 (en) Use of mob-5 in pain